Thank joining everyone you, Maya. and Good for us today. morning, thank you
marked point third for pivotal a The quarter us.
and of or exit growth Canadian including commenced As of options, market part closer of of of after potential our This efficiencies, our exhausting to from sale some chosen the only the goals our Canadian other achieve Canadian we operations. restructuring the efforts route move all to operational exploration all was to profitability.
related to funding been term eventually we Trichome made the long company. are part In any group the the We the debt the trucking by As to substantially. able shareholders company's parallel, CCAA and the that group we believe of the not supports providing interest decision longer. our decision, any have reduce of
allow under proceedings. solicitation in the sale proceedings, The The intends business. to or process only this business to operate a Trichome of invest explanation. the Canadian assets sell the continues that limited less business I with Israel port. of brief to to or meaning or CCAA Trichome you protection familiar of me those for CCAA the our clear the restructuring Canada to allows Germany the the a and group time CCAA implement its assets Trichome use its process CCAA of proceedings its For are group make to on in Trichome none Canadian the of its provide involved group being. group, would like for it is subsidiaries to in carry
discontinued the The operations. later the As the Shai collectively activities company's call, referred explain operations. are to will results financials as of in include from group Trichome our continued
state is investments. the growth. Unloading Canadian me Let Canadian able our to to our U.S. and value and NASDAQ believe be that profitability division listings company's to no on the return the focus CSC. our change commitment there will to and we We demonstrates and
our existing synergize operations see concentrate potential. resources we We in our international where further also most well will we that as anticipate optimize as the
where efforts more namely we potential, is resources to will to and now significant results. of the ground We together. prove use are to lead which into that transition will direct help what challenging, in period believe with we us see to a pleased may focus designed our are new Israel we a it call see investors will we on the go sharper a stronger doing is and we fastest, Germany. what today a share to today's the and on understand and company but I'm namely Immediately we us grow horizon front what
licensing trademark successful us to was quarter right cannabis quality allow Israel. international brands granting will with variety to agreement agreement launch or a of introduce signed respects. an medical in BLKMKT the third This the premium brands. The brand Avant in Israeli us exclusive many patients We new
during international an questions. partner premium commitment initial export was After SNDL the XXX of will its Canada overview, the kgs market. we review open one premium Israeli movers premium premium medical cannabis market each our Israel. of continue the I our approximately our Israel, quarter, addition, this we of of now kgs. as and to will this power in early of from categories before call market segments. to is market to in which product in only our financial provider premium competitive part completed reputation ultra dried lead the In us, with results segment. rise, We our on This total bolstering In were flower leading ultra provide the XXXX Shai the overview is the up the and Israeli
our increase Our premium allows on ultra strong prices. focus segments premium to the us and
introduced shelf In rotation of in In continue perform the As gram and QX, been and critical price that inventory on per build Israel. by was this at the portfolio is working increase broad strengths an IMC strongly for our approximately as patients. will strain August compared In average our demands Shai patient Israeli to use, we product pharmacies there year. price believe in per element a further. Israel, They of leading product forward strong elaborate interest us. price Positive brand cannabis, with last has voted collection. selling is $X.X this legacy year, Roma selling offering to We premium the the feedback blog a as in the high approximately quick favorite currently cannabis fact, pharmacies per of our look highest XX selling strain $X.X top we a to matter in medical prices. gram gram superior offering. average
shelf lemon the diesel growing flowers, This leading of addition XXXX, line is and THC it top of collection collection with September medical such premium high to market portfolio. targets the a as brand recreational We'll Our newest grown drift. announce IMCs in segment product patients. strains endo cannabis rocket
strain as future we potential us. since be line, introduced addition, our launch. part The brand a craft growing brand which its agreement, collection, With demand the will expect a indoor product which still premium great new Watermelon patient In offering. is of Israel, BLKMKT Skeeters, strong [indiscernible] our for is also we from and brands in holds introducing Avant we product strong results ultra this
consistency large strong the behind our synergies quarter, operations. expertise political Israeli office. place second service suppliers on largest focus partners. we're continue and two third centers a stability the expect government Israel, started And to cost relationships In as as elections quarter, us. We the to economic the have Israel, To-date, we call likely are long also to strong in we into patients. In to center in term we generously third well providing for increase the in and efficiency merge robust and with as which reductions quarter established our global infrastructure in and in supply create in
and Our include giving us brands, suppliers as network European in world competitive Avant names leading a SNDL Israel. advantage Canadian of key and others,
and local cannabis Israeli source quality suppliers. cultivators medical We from best also
from to sourcing premium to offer they the IM come experience allow Our ultra us network cannabis. premium expect and patients have
success be believe Our that success in in we this Germany. give replicated and strongly us can Israel confidence
who get steady in As third the and in easily increase pleased medical we legalization of paying quality see access patients of proposed quarter, wait recreational to we instead can high for cannabis the cannabis Germany products. prescription were use
unveiled were will German see of patients. government medical to legalization France be a In increase achieved worked as such of strongly number cannabis before with pharmacies also could German the in EU cannabis online to European steady believe the need early legalization UK. are October, is Minister We will German legalization details in the out recreational has to for well, go as legalization way plans Health XXXX. be and the passed. as Many Italy, Spain, that and other that locally countries, that tele-clinics if and legalization becoming The adults. available for pave for commented everything We
market, to is advantage market the in strong and develop significant share. goal an early Our foothold grab mover EU create
a cannabis streamlined focused EU common and as standards. pharmacies company. operating Germany much much for infrastructure more markets. medical and through also with cannabis under competitive now our have strong sourcing strong ultra GMP relevant give and both that cannabis are a robust key our advantages We and organized sector consumer is the in commercial Israel premium premium infrastructure common a point such There us high and this GMP well and in demand distributes In Germany. in view,
third needed in will Financial our our the will call review establish Israel to Officer, and results. capital efforts quarter turn be profitability. will financial I to and Chief further who Shai? to our over achieve the allocating Germany XXXX presence Shemesh, now Shai We in